TY - JOUR
T1 - Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome
AU - Oron, Tal
AU - Lebenthal, Yael
AU - De Vries, Liat
AU - Yackobovitch-Gavan, Michal
AU - Phillip, Moshe
AU - Lazar, Liora
PY - 2012/2
Y1 - 2012/2
N2 - Objective: To assess the interrelationship between extent of adrenarche at presentation in girls with precocious adrenarche (PA) born appropriate for gestational age and their growth pattern, pubertal course and adult height. Study design: We reviewed clinical and laboratory data from medical charts of 85 girls with PA aged 5.0 to 8.8 years at referral, stratified in 3 subgroups according to bone age (BA) minus chronological age (CA) ≤0 years; 0 1 year. Results: Extent of pubarche and dehydroepiandrosterone-sulfate levels were greatest in the BA-CA >1 subgroup (P =.02, P =.008, respectively), who also were taller at diagnosis (P =.002) and during childhood (P =.01). In all subgroups, pubertal onset was within normal range; menarche occurred earlier than in control subjects (P <.02); all attained adult height within their mid-parental height range. Predicted adult height was overestimated in girls with BA ≤CA (P =.04) and underestimated with BA-CA >1 (P <.001). Conclusions: Although a more pronounced adrenarche and BA advancement at diagnosis in girls with PA born appropriate for gestational age had an impact on their pre-pubertal growth pattern, it was not associated with early and rapid progression of puberty or reduced adult height. This reassuring clinical course indicates that PA is a benign condition, irrespective of the extent of adrenarche at presentation. Adult height prediction is unreliable in PA.
AB - Objective: To assess the interrelationship between extent of adrenarche at presentation in girls with precocious adrenarche (PA) born appropriate for gestational age and their growth pattern, pubertal course and adult height. Study design: We reviewed clinical and laboratory data from medical charts of 85 girls with PA aged 5.0 to 8.8 years at referral, stratified in 3 subgroups according to bone age (BA) minus chronological age (CA) ≤0 years; 0 1 year. Results: Extent of pubarche and dehydroepiandrosterone-sulfate levels were greatest in the BA-CA >1 subgroup (P =.02, P =.008, respectively), who also were taller at diagnosis (P =.002) and during childhood (P =.01). In all subgroups, pubertal onset was within normal range; menarche occurred earlier than in control subjects (P <.02); all attained adult height within their mid-parental height range. Predicted adult height was overestimated in girls with BA ≤CA (P =.04) and underestimated with BA-CA >1 (P <.001). Conclusions: Although a more pronounced adrenarche and BA advancement at diagnosis in girls with PA born appropriate for gestational age had an impact on their pre-pubertal growth pattern, it was not associated with early and rapid progression of puberty or reduced adult height. This reassuring clinical course indicates that PA is a benign condition, irrespective of the extent of adrenarche at presentation. Adult height prediction is unreliable in PA.
UR - http://www.scopus.com/inward/record.url?scp=84855669945&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2011.08.009
DO - 10.1016/j.jpeds.2011.08.009
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 21907353
AN - SCOPUS:84855669945
SN - 0022-3476
VL - 160
SP - 308
EP - 313
JO - Journal of Pediatrics
JF - Journal of Pediatrics
IS - 2
ER -